TOP STORIES

• REGULATORY MHLW to Support Healthcare-Related Startups from “Long-Term Perspective”: Health Minister Shiozaki
  August 1, 2017

• REGULATORY Drug Pricing Overhaul Must Strike Balance between Benefits and Costs: Health Insurance Bureau Chief
  July 31, 2017

• BUSINESS Chugai Nets Half-Year Revenue Rise on Milestone Income
  July 28, 2017

• REGULATORY Chuikyo Scrutiny Continues for Cost Calculation Pricing Formula
  July 27, 2017

• REGULATORY Chuikyo Members at Odds over How to Proceed with “CEA” Debate
  July 27, 2017

• BUSINESS Linzess Off to Solid Start, Astellas Eyes Big Indication Addition
  July 26, 2017

• BUSINESS Novartis Japan Revenue Nearly Hit Bottom, FY2016 Sales Down 3.7%: New Chief
  July 25, 2017

• BUSINESS (Update) Mitsubishi Tanabe to Buy Israel’s NeuroDerm for US$1.1 Billion
  July 25, 2017

• BUSINESS Mitsubishi Tanabe to Buy Israel’s NeuroDerm for US$1.1 Billion
  July 24, 2017

• BUSINESS Asahi Kasei Pharma to Expand Lineup in Orthopedic Field, Boost Osteoporosis Market Share through Once-Yearly Formulation of Reclast
  July 24, 2017

• ACADEMIA Hypertension Treatment Guidelines for Elderly Finalized with Recommendations on Dosage Reduction, Discontinuation
  July 21, 2017

• REGULATORY Panel OKs 42.12 Million Yen Price Tag for Drug Makers’ MID-NET Use in PMS
  July 20, 2017

• ORGANIZATION New Chuikyo Doctor Reps Question Drug Pricing Premiums, CEA Plan
  July 19, 2017

• BUSINESS Probe Finds No HQ Instruction for Improper Patient Info Acquisition in Xarelto Surveys, Bayer Execs Take 3-Month Pay Cuts
  July 18, 2017

• REGULATORY Drug Price Cut Only Way to Eke Out FY2018 Funding, though Pharmas Important: Top MD Bureaucrat
  July 14, 2017

• ACADEMIA JSHR to Conduct 20-Year Follow-Up Study in Up to 100,000 Patients to Determine Efficacy of H. Pylori Eradication Therapy at Preventing Stomach Cancer
  July 14, 2017

• REGULATORY Chuikyo Starts Debate on Interim Report on CEA, Industry Hearings Slated for Next Meeting
  July 13, 2017

• REGULATORY MHLW to Announce Data Required for Conditional Early Approval
  July 12, 2017

• ACADEMIA New Treatment GL for Advanced HCC to Be Issued in October, Will Recommend Nexavar for 1st-Line Treatment
  July 11, 2017

• BUSINESS Chugai, Osaka Univ. Immunology Collaboration Gets Underway
  July 11, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 152
• 153
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• …
• Next ›
• 最終 »